The impact of non-model-related variability on blood glucose prediction

Diabetes Technology and Therapeutics

Volumn 9, Issue 4, 2007, Pages 363-371

  Kildegaard, Jonas ^a   Randløv, Jette ^b   Poulsen, Jens Ulrik ^b   Hejlesen, Ole K ^a  

^a AALBORG UNIVERSITY   (Denmark)

^b NOVO NORDISK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; GLUCOSE; INSULIN ASPART; NEUTRAL INSULIN;

ARTICLE; BLOOD GLUCOSE MONITORING; CARBOHYDRATE INTAKE; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; INSULIN BLOOD LEVEL; INSULIN INFUSION; INSULIN METABOLISM; MEAL; PRIORITY JOURNAL; SIMULATION;

BLOOD GLUCOSE; COMPUTER SIMULATION; EATING; HUMANS; INSULIN; MODELS, BIOLOGICAL; MONTE CARLO METHOD; PREDICTIVE VALUE OF TESTS;

EID: 34548324022     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2006.0039     Document Type: Article

References (40)

1. Hovorka R, Canonico V, Chassin LJ, Haueter U, Massi-Benedetti M, Orsini-Federici M, Pieber TR, Schaller HC, Schaupp L, Vering T, Wilinska ME: Non-linear model predictive control of glucose concentration in subjects with type 1 diabetes. Physiol Meas 2004;25:905-920.
2. Plank J, Blaha J, Cordingley J, Wilinska ME, Chassin LJ, Morgan C, Squire S, Haluzik M, Kremen J, Svacina S, Toller W, Plasnik A, Ellmerer M, Hovorka R, Pieber TR: Multicentric, randomized, controlled trial to evaluate blood glucose control by the model predictive control algorithm versus routine glucose management protocols in intensive care unit patients. Diabetes Care 2006;29:271-276.
3. Albisser AM, Baidal D, Alejandro R, Ricordi C: Home blood glucose prediction: clinical feasibility and validation in islet cell transplantation candidates. Diabetologia 2005;48:1273-1279.
4. Hejlesen OK, Andreassen S, Hovorka R, Cavan DA: DIAS - the Diabetes Advisory System: an outline of the system and the evaluation results obtained so far. Comput Methods Programs Biomed 1997;54:49-58.
5. Lehmann ED, Deutsch T: A physiological model of glucose-insulin interaction in type 1 diabetes mellitus. J Biomed Eng 1992;14:235-242.
6. Lehmann ED, Deutsch T: Compartmental models for glycaemic prediction and decision-support in clinical diabetes care: promise and reality. Comput Methods Programs Biomed 1998;56:193-204.
7. Heinemann L: Variability of insulin absorption and insulin action. Diabetes Technol Ther 2002;4:673-682.
8. Alto WA, Meyer D, Schneid J, Bryson P, Kindig J: Assuring the accuracy of home glucose monitoring. J Am Board Fam Pract 2002;15:1-6.
9. Santiago OM, Khutoryansky NM, Bilbo CM, Lawton SA, Kristensen CM: Accuracy and precision of the NovoPen 3 insulin delivery device after mechanical and temperature stresses. Endocr Pract 2002;8:351-355.
10. Berger M, Rodbard D: Computer simulation of plasma insulin and glucose dynamics after subcutaneous insulin injection. Diabetes Care 1989;12:725-736.
11. Bergman RN, Ider YZ, Bowden CR, Cobelli C: Quantitative estimation of insulin sensitivity. Am J Physiol 1979;236:E667-E677.
12. Bergman RN: The minimal model: yesterday, today and tomorrow. In: The Minimal Model Approach and Determination of Glucose Tolerance, Louisiana State University Press, Baton Rouge, 1997:3-50.
13. Furler SM, Kraegen EW, Smallwood RH, Chisholm DJ: Blood glucose control by intermittent loop closure in the basal mode: computer simulation studies with a diabetic model. Diabetes Care 1985;8:553-561.
14. Vicini P, Caumo A, Cobelli C: Glucose effectiveness and insulin sensitivity from the minimal models: consequences of undermodeling assessed by Monte Carlo simulation. IEEE Trans Biomed Eng 1999;46:130-137.
15. Østerberg O, Erichsen L, Ingwersen SH, Plum A, Poulsen HE, Vicini P: Pharmacokinetic and pharmacodynamic properties of insulin aspart and human insulin. J Pharmacokinet Pharmacodyn 2003;30:221-235.
16. Heinemann L, Weyer C, Rauhaus M, Heinrichs S, Heise T: Variability of the metabolic effect of soluble insulin and the rapid-acting insulin analog insulin aspart. Diabetes Care 1998;21:1910-1914.
17. Skeie S, Thue G, Nerhus K, Sandberg S: Instruments for self-monitoring of blood glucose: comparisons of testing quality achieved by patients and a technician. Clin Chem 2002;48:994-1003.
18. Graff MR, Gross TM, Juth SE, Charlson J: How well are individuals on intensive insulin therapy counting carbohydrates? [abstract]. Diabetes Res Clin Pract 2000;50(Suppl):S238.
19. Kalergis M, Pacaud D, Strychar I, Meltzer S, Jones P, Yale JF: Adherence and accuracy with carbohydrate counting in intensive diabetes management [abstract 0521]. Diabetes 1997;46(Suppl 1).
20. Metropolis N, Ulam S: The Monte Carlo method. J Am Stat Assoc 1949;44:335-341.
21. Clarke WL, Cox D, Gonder-Frederick LA, Carter W, Pohl SL: Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care 1987;10:622-628.
22. Albisser AM, Sakkal S, Wright C: Home blood glucose prediction: validation, safety, and efficacy testing in clinical diabetes. Diabetes Technol Ther 2005;7:487-496.
23. th Scandinavian Conference on Health Informatics. Aalborg, Denmark: Virtual Centre for Health Informatics, 2006:47-51.
24. Meltzer LJ, Johnson SB, Pappachan S, Silverstein J: Blood glucose estimations in adolescents with type 1 diabetes: predictors of accuracy and error. J Pediatr Psychol 2003;28:203-211.
25. Schwingshandl J, Borkenstein M: [Accuracy of blood-glucose awareness in children with type-I diabetes]. Wien Klin Wochenschr 1993;105:382-384.
26. Uchigata Y, Kawatahara M, Ohsawa M, Miura J, Okudaira M, Takaike H, Iwamoto Y: Characteristics and learning effects of the predictability of the self-monitored blood glucose level in children with type 1 diabetes. Diabetes Res Clin Pract 2004;65:79-83.
27. Gonder-Frederick LA, Snyder AL, Clarke WL: Accuracy of blood glucose estimation by children with IDDM and their parents. Diabetes Care 1991;14:565-570.
28. Mougiakakou SG, Nikita KS: Blood glucose profile prediction for type 1 diabetes patients using a hybrid approach. Eur Med Biol Eng Conference 2002;1160-1161.
29. Homko C, Deluzio A, Jimenez C, Kolaczynski JW, Boden G: Comparison of insulin aspart and lispro: pharmacokinetic and metabolic effects. Diabetes Care 2003;26:2027-2031.
30. Plank J, Wutte A, Brunner G, Siebenhofer A, Semlitsch B, Sommer R, Hirschberger S, Pieber TR: A direct comparison of insulin aspart and insulin lispro in patients with type 1 diabetes. Diabetes Care 2002;25:2053-2057.
31. Danne T, L pke K, Walte K, Von SW, Gall MA: Insulin detemir is characterized by a consistent pharmacokinetic profile across age-groups in children, adolescents, and adults with type 1 diabetes. Diabetes Care 2003;26:3087-3092.
32. Lepore M, Pampanelli S, Fanelli C, Porcellati F, Bartocci L, Di VA, Cordoni C, Costa E, Brunetti P, Bolli GB: Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes 2000;49:2142-2148.
33. Lepore M, Pampanelli S, Fanelli C, Porcellati F, Bolli GB: Pharmacokinetics and dynamics of S.C. injection of insulin glargine, NPH and ultralente in T1DM: comparison with CSII [abstract]. Diabetologia 2000;43:A197.
34. Perriello G, De-Feo P, Torlone E, Fanelli C, Santeusanio F, Brunetti P, Bolli GB: The dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity. Diabetologia 1991;34:21-28.
35. Pimenta WP, Santos M, Aragon FF, Padovani CR: Metabolic and hormonal circadian rhythms in subjects with impaired glucose tolerance [abstract]. Diabetologia 2005;48:A224-A225.
36. Surwit RS, Schneider MS: Role of stress in the etiology and treatment of diabetes mellitus. Psychosom Med 1993;55:380-393.
37. Vranic M, Miles P, Rastogi K, Yamatani K, Shi Z, Lickley L, Hetenyi G: Effect of stress on glucoregulation in physiology and diabetes. Adv Exp Med Biol 1991;291:161-183.
38. Goodyear LJ, Kahn BB: Exercise, glucose transport, and insulin sensitivity. Annu Rev Med 1998;49:235-261.
39. Guelfi KJ, Youngs LM, Jones TW, Fournier PA: The risk of hypoglycemia is not increased during early recovery from intermittent high-intensity exercise in individuals with type 1 diabetes mellitus [abstract]. Diabetes 2004;53:A261.
40. Guelfi KJ, Jones TW, Fournier PA: The decline in blood glucose levels is less with intermittent high-intensity compared with moderate exercise in individuals with type 1 diabetes. Diabetes Care 2005;28:1289-1294.